About Spectrumedics
Spectrumedics is a company based in Singapore (Singapore) founded in 2018 by Peng Huiqun, Al Ray Tabiliran, and Elynn Phang. Spectrumedics has raised $14.99 million across 1 funding round from investors including Legend Capital, BC Capital and Yangyun Capital. Spectrumedics offers products and services including Targeted Treatment Device. Spectrumedics operates in a competitive market with competitors including Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.
- Headquarter Singapore, Singapore
- Founders Peng Huiqun, Al Ray Tabiliran, Elynn Phang
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spectrumedics International Pte. Ltd.
-
Annual Revenue
$152.11 K (USD)183as on Dec 31, 2023
-
Net Profit
-$576.04 K (USD)19as on Dec 31, 2023
-
EBITDA
-$576.04 K (USD)19as on Dec 31, 2023
-
Total Equity Funding
$14.99 M (USD)
in 1 rounds
-
Latest Funding Round
$14.99 M (USD), Series A
May 07, 2022
-
Investors
Legend Capital
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spectrumedics
Spectrumedics offers a comprehensive portfolio of products and services, including Targeted Treatment Device.
Device for seamless and precise medical treatments
Funding Insights of Spectrumedics
Spectrumedics has successfully raised a total of $14.99M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.99 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spectrumedics
Spectrumedics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Legend Capital, BC Capital and Yangyun Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture Capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Spectrumedics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spectrumedics
Investment portfolio details for Spectrumedics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spectrumedics
Detailed financials for Spectrumedics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spectrumedics Comparisons
Peer comparison for Spectrumedics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spectrumedics
Spectrumedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orchestra BioMed, Biotronik, Inquis Medical, Synaptic Medical and Shenzhen Hannuo Medical Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for hypertension and atherosclerosis treatment are developed.
|
|
| Locked | Locked | Locked |
Cardiovascular products and equipment are developed, manufactured, and distributed.
|
|
| Locked | Locked | Locked |
Developer of medical device for the treatment of peripheral thrombectomy
|
|
| Locked | Locked | Locked |
Medical devices for cardiac arrhythmias and cardiovascular diseases are developed.
|
|
| Locked | Locked | Locked |
Extracorporeal circulation products including ECMO are developed for medical support.
|
Detailed competitors of Spectrumedics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spectrumedics
Complete news archive for Spectrumedics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spectrumedics
Spectrumedics was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Spectrumedics is headquartered in Singapore, Singapore.
Elynn Phang is the current CEO of Spectrumedics. They have also founded this company.
Spectrumedics is a funded company, having raised a total of $14.99M across 1 funding round to date.
Annual revenue of Spectrumedics is $152.11K as on Dec 31, 2023.
Manufacturer of a therapeutic device for the treatment of arterial vascular calcification. The company has developed a product named Sonico- an intravascular shock wave balloon catheter system for treating arterial vascular calcification using shock wave therapy.
Spectrumedics's top competitors include Orchestra BioMed, Biotronik and Inquis Medical.
Spectrumedics offers Targeted Treatment Device.
Spectrumedics has 4 investors. Key investors include Legend Capital, BC Capital, Yangyun Capital, and Wilder Capital.